The global paresthesia treatment market is anticipated to grow at a CAGR of 3.6% during the forecast period (2024-2031). Treatment for paresthesia can include medications such as anticonvulsants, tricyclic antidepressants, and pain relievers; neuromodulation devices, that deliver electrical impulses to the nerves; physical therapy and rehabilitation programs; orthopedic devices such as braces, splints, and orthotic insoles; and lifestyle and dietary modifications to address any nutritional deficiencies. The market’s growth is attributed to increasing rate of diabetes across the globe. Furthermore, the market for treatments for paresthesia is significantly influenced by the rising incidence of diabetes throughout the globe. As previously indicated, a significant portion of individuals with diabetes can acquire neuropathy at some point in their lives that raises the need for efficient therapies.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/paresthesia-treatment-market
For instance, in October 2023, Boston Scientific Corp., received FDA (Food and Drug Administration) approval for an expanded indication of the WaveWriter Alpha Spinal Cord Stimulator (“SCS”) Systems. That can influence the body’s lower extremities. Diabetic neuropathy is a type of nerve damage throughout the body, often impacting the nerves in the legs and feet. Over time, elevated levels of glucose in the blood can damage these nerves, leading to sensations of pain and numbness in the legs, feet and hands. The Center for Disease Control and Prevention (CDC) reports that 37.3 million Americans, or 11.3% of the US population, live with diabetes, and it is estimated that 50.0% of adults with diabetes will experience neuropathy during their lifetime.
Global Paresthesia Treatment Market Report Segment
By Type
- Chronic Paresthesia
- Acute Paresthesia
By Treatment
- Immunosuppressant
- Anticonvulsants
- Topical Creams
- Antivirals
- Others (Physical Therapy, and Vitamin Deficiencies)
By Distribution Channel
- Online Retailers
- Hospitals and Healthcare Facilities
- Retail Pharmacy
- Others (Government Procurement, and Specialized Clinics and Pain Management Centers)
A full report of Paresthesia Treatment Market available @ https://www.omrglobal.com/industry-reports/paresthesia-treatment-market
Global Paresthesia Treatment Market Report Segment by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Rest of the World
- Latin America
- Middle East & Africa
Company Profiles
- Bio-Medical Research Ltd.
- Boston Scientific Corp.
- Cipla Ltd.
- EnteroMedics Inc.
- Forbes Media LLC
- GlaxoSmithKline
- Glenmark Pharmaceuticals Ltd.
- Medtronic Pvt Ltd.
- Merck & Co., Inc.
- Neurospine Institute
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
